Cushman & Wakefield (NYSE:CWK – Get Free Report) and Gyrodyne (NASDAQ:GYRO – Get Free Report) are both finance companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, valuation, earnings, institutional ownership, analyst recommendations and dividends.
Risk and Volatility
Cushman & Wakefield has a beta of 1.47, meaning that its stock price is 47% more volatile than the S&P 500. Comparatively, Gyrodyne has a beta of 0.47, meaning that its stock price is 53% less volatile than the S&P 500.
Institutional and Insider Ownership
95.6% of Cushman & Wakefield shares are held by institutional investors. Comparatively, 71.4% of Gyrodyne shares are held by institutional investors. 0.5% of Cushman & Wakefield shares are held by company insiders. Comparatively, 12.1% of Gyrodyne shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Analyst Recommendations
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Cushman & Wakefield | 0 | 5 | 5 | 0 | 2.50 |
| Gyrodyne | 0 | 0 | 0 | 0 | 0.00 |
Cushman & Wakefield presently has a consensus price target of $17.88, indicating a potential upside of 7.65%. Given Cushman & Wakefield’s stronger consensus rating and higher possible upside, analysts clearly believe Cushman & Wakefield is more favorable than Gyrodyne .
Valuation and Earnings
This table compares Cushman & Wakefield and Gyrodyne “s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Cushman & Wakefield | $9.45 billion | 0.41 | $131.30 million | $0.96 | 17.30 |
| Gyrodyne | N/A | N/A | N/A | N/A | N/A |
Cushman & Wakefield has higher revenue and earnings than Gyrodyne .
Profitability
This table compares Cushman & Wakefield and Gyrodyne ‘s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Cushman & Wakefield | 2.23% | 14.69% | 3.60% |
| Gyrodyne | N/A | N/A | N/A |
Summary
Cushman & Wakefield beats Gyrodyne on 9 of the 10 factors compared between the two stocks.
About Cushman & Wakefield
Cushman & Wakefield Plc engages in the provision of commercial real estate services. It operates through the following geographical segments: Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific (APAC). The Americas segment consists of operations located in the United States, Canada and key markets in Latin America. The EMEA segment includes operations in the UK, France, Netherlands and other markets in Europe and the Middle East. The APAC segment comprises of operations in Australia, Singapore, China and other markets in the Asia Pacific region. The company was founded in 1917 and is headquartered in London, the United Kingdom.
About Gyrodyne
Gyrodyne, LLC owns and manages a diversified portfolio of real estate properties comprising office, industrial and service-oriented properties in the New York metropolitan area. Gyrodyne owns a 63 acre site approximately 50 miles east of New York City on the north shore of Long Island, which includes industrial and office buildings and undeveloped property which is the subject of plans to seek value-enhancing entitlements. Gyrodyne also owns a medical office park in Cortlandt Manor, New York which is also the subject of a subdivision application. Gyrodyne's common shares are traded on the NASDAQ Stock Market under the symbol GYRO.
Receive News & Ratings for Cushman & Wakefield Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cushman & Wakefield and related companies with MarketBeat.com's FREE daily email newsletter.
